Registry for early-onset Parkinson's disease in China
Official title: The Chinese Early-onset Parkinson's Disease Registry
Run by Xiangya Hospital of Central South University · NCT03508960 · Data updated 2026-11-12
This study is creating a database to learn more about early-onset Parkinson's disease in China by looking at symptoms, genetics, and environmental factors in people diagnosed with the condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 50 Years |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | February 1, 2017 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | May 11, 2018 |
| Trial ID | NCT03508960 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Parkinson's disease before the age of 50 without a family history of the condition.
✕Probably not a fit
Patients with a family history of Parkinson's disease may not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Chinese Early-onset Parkinson's Disease Registry aims to create a comprehensive database of individuals diagnosed with early-onset Parkinson's disease in China. This observational study will assess clinical features, genetic factors, and environmental influences associated with the condition. Participants will undergo various neurological tests and scales to evaluate their symptoms, while blood samples will be collected for genetic analysis. Additionally, questionnaires will be used to gather information on environmental exposures such as smoking and pesticide use.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of early-onset Parkinson's disease and lead to improved diagnosis and treatment strategies.
How similar studies have gone: While there have been various studies on Parkinson's disease, this specific registry focusing on early-onset cases in China is a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with PD by UKBB and other standard criteria Age of onset is no more than 50 years old. Exclusion Criteria: * Patients have a family history of PD.
Where it's running
-
Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting
Study contacts
- Study coordinator: J Guo, Ph.D.
- Email: guojifeng2003@163.com
- Phone: +8613974936815
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.